Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2015. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3037500017 | Secukinumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3037626016 | Secukinumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 737601000241117 | sécukinumab (substance) | fr | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| 839651000172119 | sécukinumab | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Secukinumab | est un(e) (attribut) | Immunosuppressant (substance) | true | Inferred relationship | Some | ||
| Secukinumab | est un(e) (attribut) | Monoclonal antibody agent (substance) | false | Inferred relationship | Some | ||
| Secukinumab | est un(e) (attribut) | Monoclonal antibody (substance) | true | Inferred relationship | Some | ||
| Secukinumab | Has disposition (attribute) | Immunomodulator (disposition) | true | Inferred relationship | Some | ||
| Secukinumab | est un(e) (attribut) | anticorps monoclonal chimérique souris-humain d'isotype IgG | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Secukinumab only product | a pour principe actif (attribut) | True | Secukinumab | Inferred relationship | Some | 1 |
| Product containing secukinumab in parenteral dose form (medicinal product form) | a pour principe actif (attribut) | True | Secukinumab | Inferred relationship | Some | 1 |
| Secukinumab only product in parenteral dose form | a pour principe actif (attribut) | True | Secukinumab | Inferred relationship | Some | 1 |
| Secukinumab therapy (procedure) | substance utilisée (attribut) | True | Secukinumab | Inferred relationship | Some | 1 |
| Secukinumab 150 mg/mL solution for injection | Has precise active ingredient | True | Secukinumab | Inferred relationship | Some | 1 |
| Secukinumab 150 mg/mL solution for injection | Has basis of strength substance (attribute) | True | Secukinumab | Inferred relationship | Some | 1 |
| Product containing secukinumab (medicinal product) | a pour principe actif (attribut) | True | Secukinumab | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR